Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
(2006) Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation
with C-terminal 8*His ASCREVCCPVGPSGLRCTRAGSLDTLRGLRGAGNLTELYVENQQHLQRLEFEDLQGLGELRSLTIVKSGLRFVAPDAFRFTPRLSHLNLSSNALESLSWKTVQGLSLQDLTLSGNPLHCSCALFWLQRWEQEGLCGVHTQTLHDSGPGDQFLPLGHNTSCGVPTVKIQMPNDSVEVGDDVFLQCQVEGLALQQADWILTELEGAATVKKFGDLPSLGLILVNVTSDLNKKNVTCWAENDVGRAEVSVQVSVSFPASVHLGLAVEQHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTQFLESALTNETMRHGCLRLNQPTHVNNGNYTLLAANPYGQAAASVMAAFMDNPFEFNPEDPIPVSFSPVDGNSTSRDPVEKKDETPFGGGGSHHHHHHHH
Expression System HEK293 Molecular Weight 60-65kDa (Reducing) Purity >95% by SDS-PAGE&RP-HPLC
the hydrophobic fusion peptide is unmasked and induces the fusion between host cell and virion membranes
The standard mother solution without dilution can be used as the highest point of the standard curve (250 pg/mL)
p21 Waf1/Cip1 Mouse mAb (469-2) Size:25μl (2006) Human MICL (CLEC12A) isProduct Specification Host Mouse Antigen p21 Waf1 Cip1 Synonyms WAFT, Cyclin dependent kinase inhibitor 1, CDK interacting protein 1, MDA 6, p21, CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1 Immunogen Synthetic Peptide Location Nucleus Accession P38936 Clone Number 469 2 Antibody Type Mouse mAb Isotype IgG2a Application WB, IHC P, ICC, ICFCM Reactivity Hu Purification Protein A Concentration 2 mg ml Conjugation Unconjugated Physical Appearance Liquid